CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
114 hedge funds and large institutions have $2.67B invested in China Biologic Products Holdings, Inc. in 2015 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 45 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
8% more funds holding
Funds holding: 106 → 114 (+8)
31% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 45
Holders
114
Holding in Top 10
8
Calls
$8.43M
Puts
$7.65M
Top Buyers
| 1 | +$114M | |
| 2 | +$46.3M | |
| 3 | +$43.6M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$24.7M |
| 5 |
ICP
Indus Capital Partners
New York
|
+$21.7M |
Top Sellers
| 1 | -$37.2M | |
| 2 | -$20.1M | |
| 3 | -$15.9M | |
| 4 |
Two Sigma Investments
New York
|
-$13.8M |
| 5 |
VAM
Visium Asset Management
New York
|
-$13.4M |